The firm is already raising its next round at a valuation of about $1.8 billion
API Holdings Pvt., one of India s largest digital pharmacies, announced on Wednesday that it has raised $350 million from Prosus Ventures and TPG Growth LLC. The company was valued at close to $1.5 billion, according to a person familiar with the deal, adding to a rapidly growing list of unicorn startups in the country.
The firm is already raising its next round at a valuation of about $1.8 billion, the person said, wishing to remain anonymous as the fresh round is still underway.
The Mumbai-headquartered company said it will use the funds to expand its pharmacy network and add more tele-consultations to link up customers with the 60,000 brick-and-mortar pharmacies and 4,000 doctors it already has on its books. Existing investors including Temasek Holdings Pte and CDPQ participated in the Series E round.
For the third consecutive day, a new unicorn is born from India as PharmEasy joins the billion dollar club
businessinsider.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.in Daily Mail and Mail on Sunday newspapers.
India s E-pharmacy segment mints its first unicorn, raises $350 million
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.
More than 10 percent of children hospitalized with COVID-19 or multisystem inflammatory syndrome, an inflammatory condition commonly known as MIS-C that in rare cases has followed SARS-CoV-2 infection, experienced acute kidney injury, according to a study published March 3 in
Kidney International. Kids with kidney damage remained in the hospital an average of eight days longer than did other children facing these conditions without the added kidney stress.
“Recognizing that kidney function contributes to outcomes post-COVID is important to think about, especially in the pediatric population. These kids are young and have a whole life ahead of them,” says Abby Basalely, a pediatric nephrologist at Cohen Children’s Medical Center in New Hyde Park, New York, and a coauthor of the study.